How major hospitals are embracing AI chatbots to query patient records
Katie covers the impact of health technology on patients, clinicians, and businesses. Her stories explore the price tag…
Amylyx endocrine drug succeeds in key study for low blood sugar
Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected…
Enveda weight loss maintenance pill mimics exercise in early tests
If you could design an oral treatment that limits appetite and mimics some effects of physical activity, you…
Antitrust questions circling Epic Systems, nation’s largest EHR vendor
The Federal Trade Commission is examining Epic Systems Corp., the nation’s largest vendor of electronic health records, for…
My morning: Dame Valerie Adams shares her daily routine
Turn off my alarm. No snoozing allowed. How do you wake up? I aim for eight hours of…
What ‘minimally invasive’ means for patient input on brain implants
Scroll through the flashy websites of neurotechnology startups and a phrase repeats again and again: “minimally invasive.” “The…
What Medicare incentives for AI-based devices mean for tech companies — and hospitals
Katie covers the impact of health technology on patients, clinicians, and businesses. Her stories explore the price tag…
Wait times for cancer patients’ first treatments increase: study
Angus reports on the basic research, clinical science, and drug development that may transform survival and quality of…
Inside a $7 billion startup’s mad dash to automate the business of health care
Highlights Commure, a $7 billion technology company that uses AI to automate administrative tasks in health care, offers…
Stopping statins at 75 may be safe for healthy adults, Lancet study says
Not long after guidelines shifted to considering statin therapy as early as age 30, new research from France…
Pharmalittle: Sanofi experiencing drug shortages, Jazz buying Actio
Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating…
Eli Lilly to offer retatrutide access given earlier to just one patient
Lizzy leads STAT’s coverage of the FDA. Her stories explore the relationship between politics and science at the…